Stephan, P., Chohan, K. L., Redd, R. A., Dixon, W., Zou, A., Ahmed, S., Flowers, C. R., Chauhan, A., Ayers, A. A., Shouse, G., Thiruvengadam, S. K., Herrera, A. F., Bock, A. M., Epperla, N., Lunning, M. A., Salles, G., Falchi, L., Sawalha, Y., Godbole, S., Jallouk, A. P., Bhaskar, S. T., Major, A., Bair, S. M., Rodig, S. J., Armand, P., Merryman, R. W., Danilov, A. V. and Crombie, J. L. (2026) “Outcomes associated with CD3xCD20 bispecific antibody therapies in relapsed/refractory transformed indolent lymphoma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301578.